Common Variable Agammaglobulinemia

Common variable agammaglobulinemia is usually used to describe common variable immunodeficiency (CVID) – a primary immune system disease where the body makes very low levels of antibodies (immunoglobulins) such as IgG, IgA and sometimes IgM. Because antibodies are low and do not work properly, people get repeated infections of the sinuses, ears, lungs and gut, and some patients also develop autoimmune disease, lung scarring, gut inflammation and a higher risk of some cancers.

The main standard treatment is lifelong immunoglobulin replacement therapy given through the vein (IVIG) or under the skin (SCIG) to supply normal antibodies collected from donated human plasma. This greatly reduces serious bacterial infections and improves quality of life, but it does not fully “cure” the immune defect, so other supportive and preventive measures are also important.

Common variable agammaglobulinemia is a long-term problem of the immune system where the body makes very low amounts of antibodies (also called immunoglobulins), especially IgG, and often IgA and IgM. Antibodies are special proteins in the blood that help fight germs such as bacteria and viruses. When antibodies are low, the person gets many infections, especially in the ears, sinuses, lungs, and gut.[]

In real medical practice, doctors more often use the name common variable immunodeficiency (CVID) for this condition. Agammaglobulinemia means “almost no antibodies in the blood.” CVID usually causes very low, but not completely absent, antibodies. Both problems belong to a group called primary antibody deficiencies. They are usually caused by changes in genes that control B cells, the white blood cells that normally make antibodies.[]

Because the immune system does not work well, people with this disease can also develop autoimmune diseases (when the immune system attacks the body’s own cells), chronic lung damage, gut problems, and a higher risk of some cancers such as lymphoma and stomach cancer. The disease usually lasts for life and needs lifelong medical follow-up.[]

---

Other names

Doctors and books may use several other names or related names, including:

• Common variable immunodeficiency (CVID) – the most common modern name for this disease group.[]

• Common variable immune deficiency – another spelling of the same term.

• Primary antibody deficiency – the larger family of diseases that includes CVID and agammaglobulinemia.[]

• Late-onset hypogammaglobulinemia – name sometimes used when low antibodies first appear in teenagers or adults.

• Primary hypogammaglobulinemia – describes low immunoglobulins from birth or early life, not caused by drugs or other illnesses.[]

Related, but more specific, agammaglobulinemia conditions include:

• X-linked agammaglobulinemia (XLA)

• Bruton agammaglobulinemia / Bruton disease

• X-linked hypogammaglobulinemia

These related names are usually used when a clear gene change in the BTK gene on the X chromosome is found.[]

---

Types

Doctors can describe types of common variable agammaglobulinemia / CVID in different ways. Here are simple groupings.

1. Infection-predominant type
In this type, repeated infections are the main problem. People often have many ear, sinus, and lung infections but fewer autoimmune problems. The main worry is long-term lung damage, such as bronchiectasis (wide, scarred airways).[]

2. Autoimmune-predominant type
Some people have fewer infections but strong autoimmune problems. They may get autoimmune low platelets, autoimmune anemia, thyroid disease, or joint inflammation. The immune system is both weak against germs and overactive against the body’s own tissues.[]

3. Lymphoproliferative type
In this type, lymphoid tissues (lymph nodes, spleen, sometimes lungs or liver) become big and full of immune cells. People may have large lymph nodes, a big spleen, or growth-like areas in organs. This type may carry a higher risk of lymphoma (a cancer of lymphocytes).[]

4. Gastrointestinal-predominant type
Here, gut problems are a main feature. People may have long-lasting diarrhea, weight loss, poor absorption of food, or gut inflammation that looks like celiac disease or inflammatory bowel disease. Infections and autoimmunity may also be present but gut problems dominate daily life.[]

5. Granulomatous type
Some people develop granulomas, which are small tight clusters of immune cells in organs like lungs, liver, spleen, skin, or lymph nodes. These look similar to sarcoidosis on scans. Granulomas show that the immune system is reacting in a disorganized way.[]

6. Mild / oligosymptomatic type
A few people have low antibodies but only mild or rare infections, especially early in the disease. They may be picked up on blood tests done for another reason. Over time, some of them later develop more clear symptoms and need full treatment.[]

7. Type with very low or absent B cells
Some patients have very few B cells in the blood. This looks closer to classical agammaglobulinemia, where B cells fail to mature. These people often have more severe infections early in life.[]

8. LOCID (late-onset combined immunodeficiency)-like type
A subgroup has very low CD4 T-cell counts together with low antibodies. This is sometimes called LOCID. These patients may have more severe and unusual infections and a worse long-term outlook if not carefully treated.[]

---

Causes

Scientists know that the causes are mainly genetic, but for many people the exact gene is still unknown. Here are 20 important causes or contributing factors, explained in simple words.

1. Gene change in TACI (TNFRSF13B)
Changes (mutations) in the TACI gene are one of the most common known genetic causes. TACI is a protein on B cells. It helps B cells receive signals to grow and change into antibody-making cells. When TACI does not work well, B cells do not mature properly and antibody levels become low.[]

2. Gene change in ICOS
ICOS is a signal on T cells that helps them support B cells. Mutations in ICOS make it hard for T cells to “help” B cells when they meet germs. As a result, B cells cannot make strong, long-lasting antibodies.[]

3. Gene change in BAFF-R (TNFRSF13C)
BAFF-R is a receptor on B cells that receives survival signals. If BAFF-R is faulty, many B cells die early and cannot become mature antibody-producing cells. This lowers the number of B cells and antibodies in the blood.[]

4. Gene change in CD19
CD19 is a marker and signal molecule on almost all B cells. It helps boost the signal from the B-cell receptor. Mutations in CD19 disturb B-cell activation, so B cells fail to respond properly to germs and vaccines, and antibody production is poor.[]

5. Gene change in CD20 (MS4A1)
CD20 helps control calcium flow inside B cells, which is important for B-cell activation. Some people with CVID-like disease carry CD20 mutations. These changes weaken B-cell signals and reduce antibody production.[]

6. Gene change in CD21 (CR2)
CD21 is part of a complex with CD19. Together, they help B cells respond to germs coated with complement. Mutations in CD21 make B cells less sensitive to normal activation signals, so the antibody response is weak.[]

7. Gene change in CD81
CD81 supports the CD19 complex and helps shape B-cell signaling. When CD81 is abnormal, the whole B-cell receptor complex does not work well. This can lead to a CVID picture with low antibodies and frequent infections.[]

8. Gene change in NFKB1
NFKB1 is a key switch inside immune cells that turns on many defense genes. Some people with CVID-like disease have mutations in NFKB1. This weakens the ability of B cells to mature and switch from IgM to other types of antibodies.[]

9. Gene change in NFKB2
Mutations in NFKB2 can also cause CVID-like symptoms. This gene affects survival and maturation of B cells and some T cells. When it is damaged, antibody levels can be very low, and patients may also have endocrine and autoimmune problems.[]

10. Gene changes in CTLA4 or LRBA
CTLA4 is a “brake” molecule on T cells, and LRBA helps control CTLA4. Mutations in these genes can lead to uncontrolled immune activation plus low antibodies. This can look clinically like CVID with strong autoimmunity and lymphoproliferation.[]

11. Problems in helper T-cell signals (for example IL-21 pathway)
Some genes in the IL-21 pathway affect how T cells support B cells in lymph nodes. When these signals are weak, germinal centers (the training areas for B cells) do not form well. This leads to poor class switching and low IgG and IgA.[]

12. Inherited familial forms
In some families, more than one person has CVID or related disease, showing that inheritance plays a role. The pattern can be autosomal dominant (one changed copy enough) or autosomal recessive (two changed copies needed), depending on the gene.[]

13. New (de novo) gene mutations
In many patients there is no family history. The gene change may be new in that person and not present in the parents. These “de novo” mutations still disturb B-cell development, but the family tree looks normal.[]

14. Gene variants in HLA (MHC) region
Some studies show that certain HLA (MHC) types in the DR and DQ regions are more common in CVID. These variants may not directly cause the disease but can increase the chance that other risk genes will lead to low antibodies.[]

15. Multiple small-effect gene variants together
For many people, no single strong mutation is found. Instead, several smaller gene changes may combine and disturb B cells and T cells just enough to cause disease. This “polygenic” pattern is still being studied.[]

16. Defects in B-cell maturation in bone marrow
Even when the exact gene is not known, studies show that some patients have blocked steps in B-cell development in the bone marrow. This means too few mature B cells leave the marrow and reach the blood and lymphoid tissues.[]

17. Problems with class-switch recombination
Class switching is the process that changes IgM to IgG, IgA, or IgE. In CVID, this process is often faulty, so the body cannot make enough switched antibodies. This is one reason why IgG and IgA are especially low.[]

18. Abnormal regulatory T-cell function
Regulatory T cells normally calm down immune responses and prevent autoimmunity. In many CVID patients, these cells are fewer or work poorly. This may explain why autoimmunity is common together with low antibodies.[]

19. Environmental triggers in genetically prone people
Infections or other environmental factors may trigger symptoms in people who already have genetic risk. For example, a strong infection might reveal an underlying antibody defect that was silent before.[]

20. Unknown or yet-undiscovered causes
In most patients, doctors still cannot find a clear gene even with modern tests. This means many causes remain unknown and are an active area of research.[]

---

Symptoms

1. Repeated ear infections
Children and adults may get otitis media many times each year. Ear infections can cause ear pain, fever, and sometimes hearing problems. These repeated infections are often one of the first warning signs.[]

2. Repeated sinus infections
Sinusitis causes facial pain, blocked nose, and thick nasal mucus. In this disease, sinus infections happen again and again because antibodies cannot clear bacteria well.[]

3. Repeated bronchitis and pneumonia
The lungs often get infected. People may have frequent cough, sputum, chest pain, and fever. Severe or repeated pneumonia can leave scars and widen the airways (bronchiectasis).[]

4. Chronic cough and breathlessness
Because of repeated lung infections, a long-term cough and shortness of breath may appear, even when there is no current infection. This comes from long-term lung damage.[]

5. Gut infections and chronic diarrhea
Many people get repeated stomach and gut infections. They may have loose stools, stomach cramps, and weight loss. Some have gut problems that look like celiac disease or inflammatory bowel disease.[]

6. Poor weight gain or weight loss
Because of infections and gut problems, some children do not grow well, and some adults lose weight. The body has to work harder to fight germs and may not absorb food normally.[]

7. Extreme tiredness (fatigue)
Chronic fatigue is common. The immune system is always under stress, and frequent infections or inflammation make people feel weak and low on energy.[]

8. Swollen lymph nodes
Lymph nodes in the neck, armpits, or groin may become large and stay that way. This happens because immune cells are constantly reacting to germs or to the body’s own tissues.[]

9. Enlarged spleen and liver
Some patients have a big spleen or big liver. Doctors may feel this on exam or see it on scans. These organs can become full of immune cells or granulomas.[]

10. Easy bruising or bleeding
If the immune system attacks platelets (immune thrombocytopenia), people may notice bruises, nosebleeds, or bleeding from gums. This is one form of autoimmunity linked with the disease.[]

11. Pale skin and shortness of breath from anemia
When the immune system attacks red blood cells (autoimmune hemolytic anemia) or when long-term inflammation lowers red blood cell production, the person looks pale and feels breathless or dizzy.[]

12. Joint pain and swelling
Joint pain or arthritis-like swelling can happen as part of autoimmunity. The joints may be stiff in the morning and painful with movement.[]

13. Skin rashes and skin infections
Some patients have bacterial or fungal skin infections, slow-healing sores, or autoimmune skin rashes. These show that both infection and autoimmunity are affecting the skin.[]

14. Shingles and other viral infections
Because antibody and sometimes T-cell responses are weak, viral infections such as shingles (herpes zoster) can occur more often and may be more severe.[]

15. Increased risk of some cancers
Over many years, some people develop lymphomas (cancers of lymphocytes) or stomach cancer. This is thought to be due to chronic immune stimulation, chronic infections, and genetic factors.[]

---

Diagnostic tests

Doctors use a mix of history, physical exam, and tests. No single test is enough. They must also rule out other causes of low antibodies.

Physical exam tests

1. Full general physical examination
The doctor looks at growth, weight, signs of chronic illness, and overall appearance. They check for pale skin, thin body build, clubbing of fingers, or signs of malnutrition. These findings suggest long-term disease, not just a short cold.[]

2. Ear, nose, and throat examination
The doctor checks the eardrums, nasal passages, and throat for signs of infection or scarring from past infections. This helps show how often and how severely the upper airways have been affected.[]

3. Chest examination with stethoscope
Listening to the lungs can reveal crackles, wheezes, or reduced breath sounds. These signs can point to pneumonia, chronic bronchitis, or bronchiectasis and guide the need for imaging.[]

4. Abdominal and lymph node examination
The doctor carefully feels the abdomen for a big liver or spleen and checks lymph nodes in the neck, armpits, and groin. Enlarged organs or nodes suggest ongoing immune activation or lymphoma risk.[]

Manual / bedside functional tests

5. Simple breathing tests (peak flow or bedside spirometry)
A basic breathing test measures how fast air can be blown out. Low values can show lung damage or ongoing disease and may push the doctor to order more detailed lung tests.[]

6. Chest percussion and expansion check
The doctor taps on the chest and watches how much the chest expands with breathing. Dull sounds or poor expansion can suggest areas of infection, collapse, or scarring in the lungs.[]

7. Joint movement examination
The doctor gently moves joints and asks about pain and stiffness. This helps detect arthritis or autoimmune joint disease, which are common extra features in some patients.[]

Laboratory and pathological tests

8. Complete blood count (CBC)
A CBC measures red cells, white cells, and platelets. It can show anemia, low platelets, or unusual lymphocyte counts. These findings help reveal autoimmunity or bone marrow problems linked with the immune defect.[]

9. Serum immunoglobulin levels (IgG, IgA, IgM)
This is the key lab test. People with CVID / common variable agammaglobulinemia have clearly low IgG and usually low IgA and/or IgM for their age. These low levels must be found on at least two separate tests.[]

10. IgG subclass tests
Sometimes the main IgG level looks near normal, but certain IgG subclasses are very low. Measuring subclasses helps explain repeated infections and supports the diagnosis when the pattern fits CVID.[]

11. Specific antibody response to vaccines
Doctors may measure antibodies to old vaccines (like tetanus) and give new vaccines (like pneumococcal) to see if the body can make specific antibodies. Poor or absent response, despite vaccination, is a strong sign of antibody deficiency.[]

12. Lymphocyte subset analysis by flow cytometry
This blood test counts different types of lymphocytes: B cells, T cells, and NK cells. Many patients have normal numbers of B cells, but some have low or absent B cells. T-cell numbers may also be low in certain subtypes.[]

13. Detailed B-cell phenotyping (memory B cells)
More advanced flow cytometry looks at memory B cells and class-switched memory B cells. In many patients, these cells are reduced. This pattern helps classify disease type and may predict risk of complications.[]

14. Genetic testing for known immune genes
Gene panels or whole-exome sequencing can look for mutations in TACI, ICOS, BAFF-R, CD19, CD20, CD81, NFKB1, NFKB2, BTK and many others. Finding a disease-causing variant confirms the inherited nature and may guide family counseling.[]

15. Stool and microbiology tests
Stool samples can be checked for parasites, bacteria, and viruses when diarrhea is present. Sputum or bronchoscopy samples may also be tested. These results show which germs are causing repeated infections.[]

16. Liver function tests and other organ blood tests
Blood tests for liver enzymes, kidney function, and inflammation markers help detect organ damage, chronic inflammation, or associated autoimmune liver disease.[]

Electrodiagnostic tests

17. Electrocardiogram (ECG)
An ECG records the heart’s electrical activity. It is not specific for this disease, but doctors may use it to check the heart in patients with severe infections, chest pain, or suspected pulmonary hypertension due to chronic lung disease.[]

18. Nerve conduction studies / EMG (in selected cases)
If a patient has unexplained weakness or numbness, doctors may test nerve and muscle electrical signals. These studies are not routine but can show nerve damage from infections, autoimmunity, or other overlapping conditions.[]

Imaging tests

19. Chest imaging (X-ray and CT scan)
A chest X-ray is often the first imaging test. It can show pneumonia or lung scarring. A high-resolution CT scan gives more detail and can show bronchiectasis, granulomas, or interstitial lung disease in people with long-term problems.[]

20. Abdominal imaging (ultrasound, CT, or MRI)
Ultrasound or CT of the abdomen can show a large spleen or liver and enlarged abdominal lymph nodes. These findings support the diagnosis and help rule out cancers or other serious complications.[]

---

Non-pharmacological treatments (Therapies and other measures)

1. Strict hand hygiene and infection control
   Regular hand-washing with soap, use of alcohol gels, and avoiding touching the face helps lower the number of germs entering the body. For someone with CVID, this simple habit can strongly reduce respiratory and gut infections. Good cough etiquette, using tissues and avoiding close contact with sick people are easy daily tools that reduce exposure to bacteria and viruses when the immune system is weak.

2. Vaccination of family members and close contacts
   People with CVID often cannot respond well to many vaccines, but their family members and household contacts can and should be fully vaccinated, including influenza and COVID-19 vaccines. This creates a “ring of protection” around the patient, lowering the chance that serious infections even reach them in the first place. Live vaccines may still be suitable for healthy contacts but are usually avoided in the CVID patient.

3. Avoiding live vaccines in the patient
   Because antibody responses and sometimes T-cell responses are impaired, live attenuated vaccines (such as oral polio, some measles or yellow fever vaccines) may rarely cause disease in people with CVID. Doctors usually avoid live vaccines and instead use inactivated or subunit vaccines if any vaccine is planned, and only under specialist guidance. This protects against vaccine-related complications.

4. Early self-monitoring and “infection action plan”
   Patients and families are taught to watch carefully for early symptoms of sinus, ear, chest or gut infection (such as new cough, fever, ear pain or diarrhea) and to contact their doctor early. Many centers give a written plan that explains when to call, when to go to the emergency room and when to start standby antibiotics prescribed in advance. Early treatment prevents damage to lungs and other organs.

5. Respiratory physiotherapy and airway-clearance techniques
   Repeated chest infections can cause bronchiectasis, a permanent widening of airways that traps mucus. Chest physiotherapy, breathing exercises, postural drainage, flutter devices and regular controlled coughing help move sticky mucus out of the lungs, decrease bacterial load and reduce flare-ups. This is often taught by a respiratory therapist and practiced daily at home.

6. Pulmonary rehabilitation and exercise
   Gentle but regular aerobic exercise (walking, cycling, swimming if safe) and supervised pulmonary rehabilitation programs strengthen the breathing muscles and improve lung function. In people with CVID-related lung disease, exercise can reduce breathlessness, help clear mucus and improve stamina and mental health. Exercise plans must be tailored to each patient’s fitness level and medical status.

7. Environmental control: smoke-free and clean air
   Tobacco smoke, vaping aerosols, heavy air pollution, dust and mold all irritate and damage airway linings, making infections easier. For CVID, a smoke-free home, good ventilation, use of exhaust fans and controlling humidity to prevent mold all help protect the lungs. Avoiding occupational exposures (such as chemical fumes) is also important for long-term lung health.

8. Dental and sinus care
   Teeth and sinuses can act as reservoirs of bacteria that repeatedly spill into the bloodstream or lower airways. Regular dental check-ups, good brushing and flossing, and treatment of sinus problems (such as saline rinses, nasal steroid sprays prescribed by a doctor and allergy management) can reduce chronic infection burden in CVID.

9. Individualized nutrition support
   Many patients with CVID have chronic diarrhea, malabsorption or weight loss due to gut infections or immune-mediated enteropathy. A balanced diet rich in protein, vitamins, minerals and calories supports wound healing and immune function. Dietitians may recommend small frequent meals, lactose-free diets, or specific formulas to correct deficiencies and maintain healthy body weight.

10. Allergen and irritant avoidance
    Asthma, allergic rhinitis and chronic cough are common in CVID. Reducing exposure to dust mites, pet dander, pollen and other irritants can decrease airway inflammation and lower infection risk. Measures include mattress and pillow covers, regular vacuuming with HEPA filters and keeping pets out of the bedroom, guided by allergy testing and specialist advice.

11. Smoking cessation programs
    If the patient smokes, quitting is one of the strongest protective measures to slow lung damage. Structured programs with behavioral counseling and, where appropriate, nicotine replacement or other stop-smoking aids improve success rates. Stopping smoking reduces chronic bronchitis, improves response to infection treatment and lowers risk of cancer, which is already increased in CVID.

12. Psychological support and counseling
    Living with a chronic immune disorder, frequent hospital visits and infections can cause anxiety, depression and social isolation. Psychological counseling, support groups and online patient communities provide emotional support, coping tools and practical tips for daily life. Better mental health often leads to better adherence to Ig therapy and other treatments.

13. Patient and family education programs
    Education about the disease, warning signs of infection, safe vaccines, travel tips and drug side effects helps patients and families make informed choices. Many immunology societies and patient organizations provide printed and online materials in simple language. Educated patients are more likely to stick to treatment, recognize complications early and avoid dangerous exposures.

14. Regular specialist follow-up and monitoring
    Routine visits to an immunologist (often every 3–6 months) allow careful tracking of IgG levels, lung function, CT scans when needed and screening for autoimmune disease or malignancy. Adjusting Ig doses, prophylactic antibiotics and other therapies based on this monitoring helps keep serious infections low and detects complications early.

15. Travel planning and infection-safe lifestyle
    When traveling, patients are advised to carry a medical summary, extra medications, and plan around safe food and water. Avoiding raw foods, untreated water and high-risk areas for certain infections lowers exposure. Planning infusion schedules around travel and knowing where to seek care abroad are part of a safe lifestyle strategy.

16. Work and school adjustments
    Some people need temporary changes such as remote work or flexible school attendance during peak infection seasons or after major infections. Occupational or school health teams can help adapt the environment, for example with better ventilation, allowing masks or limiting tasks that involve heavy germ exposure. This balances infection risk with social and educational needs.

17. Mask use in high-risk settings
    Wearing a well-fitting medical mask or respirator in crowded indoor spaces, health-care facilities or during outbreaks of respiratory viruses can significantly lower inhaled viral load. For someone with CVID, this is a simple mechanical barrier that reduces infections, especially during flu or COVID-19 waves or when local public health advice suggests masking.

18. Bone health and fall-prevention strategies
    Repeated steroid use and chronic inflammation can weaken bones. Weight-bearing exercise, safe sun exposure, and fall-prevention measures at home (removing loose rugs, using railings, good lighting) protect bones and reduce fracture risk. Doctors may monitor bone density and advise further treatments if needed.

19. Reproductive and pregnancy counseling
    Women and men with CVID may wish to have children. Pre-pregnancy counseling explains genetic aspects, infection risks and medication safety in pregnancy and breastfeeding. During pregnancy, Ig doses may need adjustment and infections require more careful monitoring, so planned specialist care is important.

20. Cancer surveillance and healthy lifestyle
    Because CVID slightly increases risk of lymphoma and some gastrointestinal cancers, doctors may recommend regular physical exams, blood tests, stool tests and age-appropriate screening (such as colonoscopy). Alongside this, avoiding smoking, limiting alcohol, maintaining a healthy weight and staying active all lower cancer risk and support long-term survival.

---

Drug treatments

(Doses are typical ranges from published guidance and product information; individual dosing must always be set by a specialist.)

1. Hizentra – immune globulin SCIG 20%
   Hizentra is a 20% subcutaneous human immunoglobulin solution used as replacement therapy for primary humoral immunodeficiency, including CVID. Usual maintenance dose is about 0.2–0.4 g/kg body weight per week, divided into one or several infusions, adjusted to keep IgG trough levels high and infections low. It works by supplying broad antibodies from pooled donor plasma. Common side effects are local swelling, headache and fatigue; serious but rare risks include thrombosis and kidney problems.

2. HyQvia – immune globulin 10% with recombinant hyaluronidase (SCIG)
   HyQvia combines a 10% human immunoglobulin with a recombinant human hyaluronidase to allow large volumes to be infused under the skin as infrequently as every 3–4 weeks in many patients with primary immunodeficiency. Typical dosing starts near 400–600 mg/kg every 3–4 weeks with step-up schedules. It corrects antibody deficiency, lowering serious bacterial infections. Main side effects include infusion-site reactions, headache, flu-like symptoms and a boxed warning for thrombosis.

3. Cuvitru – immune globulin SCIG 20%
   Cuvitru is an immune globulin 20% liquid for subcutaneous infusion, approved as replacement therapy in primary humoral immunodeficiency, including CVID. It is usually given once weekly (or every 2 weeks in some regimens) with total monthly doses similar to IVIG (roughly 400–600 mg/kg/month). Its mechanism is passive replacement of missing antibodies. Local site reactions are common; systemic reactions such as headache or fatigue are less frequent but possible.

4. Gammagard Liquid – IVIG 10%
   Gammagard Liquid is a 10% intravenous immunoglobulin approved for primary immune deficiency. For CVID, typical replacement dosing is 400–600 mg/kg every 3–4 weeks to achieve trough IgG levels usually above 500–800 mg/dL, adjusted for infection control. It works by providing pooled donor IgG. Adverse effects include infusion-related headaches, chills, aseptic meningitis, hemolysis, kidney injury and thromboembolic events, especially at high doses or in high-risk patients.

5. Gamunex-C – IVIG or SCIG 10%
   Gamunex-C is an immune globulin 10% product approved for several indications and widely used for primary immunodeficiency. Dosing for CVID is similar to other IVIGs (around 400–600 mg/kg every 3–4 weeks) or equivalent weekly SCIG dosing. It supplies functional IgG to prevent infections. Usual side effects are infusion-related reactions, headache, nausea and rare but serious thrombotic or kidney events.

6. Xembify – SCIG 20%
   Xembify is a 20% subcutaneous immune globulin indicated for primary immunodeficiency and used in some CVID patients as a home-based weekly or biweekly infusion. Total monthly dose matches standard IVIG replacement. It passively provides IgG antibodies. Local injection-site pain, swelling and itching are common; systemic effects such as headache and fatigue are also reported.

7. Cutaquig – SCIG 16.5%
   Cutaquig is a 16.5% immune globulin for subcutaneous use, also approved for primary immunodeficiency. It is given weekly or every other week with total monthly dose generally 0.4–0.8 g/kg, tailored to maintain protective IgG trough levels. It works the same way as other Ig products. Side effects are similar: local reactions, headache and rarely serious allergic or thrombotic events.

8. Other IVIG brands (Privigen, Octagam, Flebogamma and similar)
   Several 5–10% IVIG products are licensed as replacement therapy for primary immunodeficiency and may be chosen based on availability, patient tolerance and infusion center preference. Dosing again aims for 400–600 mg/kg every 3–4 weeks or equivalent SCIG doses, individualized by trough IgG and infections. Their mechanism and side-effect profiles are broadly similar to Gammagard and Gamunex-C.

9. Prophylactic oral antibiotics – for example, amoxicillin
   Some patients with CVID continue to have frequent infections even on Ig therapy. For them, low-dose continuous or intermittent prophylactic antibiotics such as amoxicillin may be used, for example once or twice daily during high-risk seasons, as decided by the doctor. The goal is to reduce bacterial colonization and acute infections. Side effects include allergy, diarrhea and antibiotic resistance, so this approach is used cautiously.

10. Macrolide prophylaxis – azithromycin
    Azithromycin is sometimes used at low doses several times per week in patients with bronchiectasis or chronic lung disease to reduce airway inflammation and bacterial burden. It belongs to the macrolide antibiotic class and also has anti-inflammatory effects in the lungs. Potential side effects are diarrhea, hearing changes and heart rhythm problems, so ECG monitoring may be needed in high-risk patients.

11. High-dose, short-course antibiotics for acute infections
    When CVID patients develop pneumonia, sinusitis or other infections, doctors often choose higher doses and longer courses of antibiotics (such as amoxicillin-clavulanate, ceftriaxone or levofloxacin) than in healthy people, because their immune systems clear bacteria less efficiently. The drug choice depends on local resistance patterns and culture results. Side effects vary by class (for example, diarrhea, tendon issues, allergy).

12. Systemic corticosteroids – prednisone
    Prednisone is a corticosteroid used short-term for autoimmune complications of CVID (such as autoimmune cytopenias) or severe inflammatory lung disease. It reduces immune over-activity by broadly suppressing lymphocyte function and cytokine production. Doses and duration vary widely (for example, 0.5–1 mg/kg/day initially), then tapering. Long-term use can cause weight gain, high blood pressure, diabetes, osteoporosis and infection risk, so doctors aim for the lowest effective dose.

13. Rituximab – anti-CD20 monoclonal antibody
    Rituximab is a biologic drug that targets CD20 on B cells and depletes them. It is sometimes used in CVID for severe autoimmune cytopenias, granulomatous disease or lymphoma. Typical regimens mirror those used in lymphoma or autoimmune disease. By removing abnormal B cells, it can control autoimmunity but may further reduce antibody production, so it is reserved for complex cases. Side effects include infusion reactions, infections and rare severe reactions like PML.

14. Azathioprine – immunosuppressant
    Azathioprine is an oral immunosuppressant that interferes with purine synthesis and reduces lymphocyte proliferation. It may be used in CVID patients with autoimmune complications or chronic inflammatory lung or gut disease when steroids alone are not enough. Doses are usually weight-based once daily. Side effects include bone marrow suppression, liver toxicity and infection risk, so blood counts and liver tests must be monitored.

15. Mycophenolate mofetil – immunosuppressant
    Mycophenolate selectively inhibits lymphocyte proliferation by blocking purine synthesis and is sometimes used as a steroid-sparing agent for CVID-associated autoimmunity or interstitial lung disease. Doses are usually split twice daily. Common adverse effects are gastrointestinal upset and increased infection risk; blood counts and liver function need checking.

16. Inhaled corticosteroids and bronchodilators
    For CVID patients with asthma-like symptoms or fixed obstructive lung disease, inhaled steroids (such as budesonide) and long-acting bronchodilators can reduce airway inflammation and improve breathing. They are given by inhaler or nebulizer, usually once or twice daily. Side effects include oral thrush and hoarseness (reduced by rinsing the mouth after use) and mild tremor or palpitations from bronchodilators.

17. Budesonide or similar drugs for CVID-related enteropathy
    Some patients develop chronic inflammatory diarrhea and malabsorption resembling celiac disease. Oral budesonide, a corticosteroid with high first-pass liver metabolism, may be used to reduce gut inflammation while limiting systemic steroid exposure. It is usually taken once or twice daily in controlled-release forms. Possible side effects include mild steroid-like effects such as mood changes and fluid retention.

18. Antifungal agents when needed
    When chronic lung or sinus disease is complicated by fungal infection, drugs such as itraconazole or voriconazole may be used. They work by inhibiting fungal cell membrane synthesis. Doses and duration depend on site and severity. Side effects include liver toxicity, drug interactions and, for some azoles, photosensitivity. These drugs are reserved for proven or strongly suspected fungal disease.

19. Prophylaxis against Pneumocystis or other specific organisms
    In CVID patients with additional T-cell abnormalities or those receiving strong immunosuppression, trimethoprim-sulfamethoxazole or other agents may be prescribed to prevent opportunistic infections such as Pneumocystis jirovecii pneumonia. They block folate metabolism in the pathogen. Side effects include allergy, low blood counts and kidney issues, so regular monitoring and folate status review are important.

20. Immunoglobulin dose-optimization and switching strategies
    Adjusting the dose, interval and route (IVIG vs SCIG) is itself a therapeutic strategy. Raising the monthly dose or switching from IVIG every 4 weeks to more frequent SCIG can reduce infections and improve quality of life in patients who still have infections or poor IgG trough levels. Studies suggest individualizing Ig dosing to clinical outcomes rather than a single standard number.

---

Dietary molecular supplements

(Evidence for supplements in CVID is limited; they should only be used under medical supervision and never replace immunoglobulin therapy.)

1. Vitamin D
   Vitamin D plays a role in immune regulation and bone health. Many patients with chronic illness or limited sun exposure are deficient. Doctors may prescribe 800–2000 IU daily, or higher short courses if levels are very low, checking blood levels regularly. Correcting deficiency supports immune cell function and reduces bone problems, especially in those needing steroids.

2. Vitamin A
   Vitamin A supports healthy mucous membranes in the respiratory and gut tracts, forming a physical barrier against infection. In deficiency states, careful replacement can help normalize epithelial integrity and some immune responses. Doses must be tailored because excess vitamin A is toxic and can cause liver problems and birth defects.

3. Zinc
   Zinc is essential for many enzymes and immune cell functions, including normal activity of neutrophils and lymphocytes. Supplement doses for deficiency are often 10–30 mg elemental zinc daily for a limited period, monitored by a clinician. Adequate zinc may improve resistance to infections, but too much can cause nausea, copper deficiency and immune dysfunction.

4. Iron (when iron-deficiency anemia is present)
   Chronic infections and gut disease can cause iron-deficiency anemia. Oral or occasional intravenous iron replenishes iron stores and improves oxygen-carrying capacity of red blood cells, which can reduce fatigue and improve exercise tolerance. Dosing is based on blood tests, and iron is avoided during active infections if possible because excess free iron may fuel bacterial growth.

5. Folate and vitamin B12
   Folate and B12 are needed for DNA synthesis and cell division in bone marrow and immune cells. If levels are low due to malabsorption or dietary lack, replacement (for example, folic acid 1 mg/day; B12 injections or high-dose oral tablets) can correct anemia and support immune cell production. Monitoring is needed to avoid masking B12 deficiency with folate alone.

6. Omega-3 fatty acids (fish oil)
   Omega-3 fatty acids have anti-inflammatory effects by altering eicosanoid production and cell membrane composition. In people with chronic lung or gut inflammation, they may modestly reduce inflammatory markers and symptoms when used as part of a balanced diet. Typical doses are 1–3 g/day of combined EPA/DHA, but they can increase bleeding risk in some patients.

7. Probiotics (carefully selected strains)
   Specific probiotic strains may help restore a healthier gut microbiome and support gut barrier function, which can be disturbed in CVID enteropathy. However, in severely immunocompromised patients, rare bloodstream infections from probiotics have been reported, so choice and dose must be decided by a specialist. The mechanism is modulation of gut flora and immune signaling in the intestine.

8. Oral rehydration and electrolyte solutions
   For patients with chronic diarrhea, simple oral rehydration solutions containing sodium, potassium, glucose and bicarbonate or citrate help maintain fluid and electrolyte balance. They support circulation and kidney function and reduce hospitalizations for dehydration, especially during infections. They are not immune boosters but are vital supportive care.

9. High-energy oral nutrition supplements
   When appetite is low or weight loss is a problem, ready-made high-calorie, high-protein drinks or powders provide concentrated nutrients in small volumes. They supply essential amino acids, fats, vitamins and minerals to support healing and immune function. A dietitian chooses formulas to fit lactose tolerance, fiber needs and other medical issues.

10. Calcium with vitamin D for bone protection
    Patients who receive frequent steroids or have low physical activity are at high risk of osteoporosis. Calcium (usually 1000–1200 mg/day from diet plus supplements) combined with adequate vitamin D helps maintain bone mineralization. Doctors check kidney function and urine calcium and may add other bone-protective drugs if fracture risk is high.

---

Immunity-booster / regenerative / stem-cell therapies

(These are specialist or experimental approaches; none replace immunoglobulin therapy.)

1. Hematopoietic stem cell transplantation (HSCT)
   HSCT transplants blood-forming stem cells from a donor to the patient after chemotherapy. It can cure some primary immunodeficiencies but is rarely used for typical CVID because Ig replacement is effective and HSCT carries significant risks such as graft-versus-host disease and severe infections. It may be considered in selected patients with life-threatening complications or unusual genetic forms under expert guidance and clinical trial conditions.

2. Experimental gene-therapy approaches
   For a few primary immunodeficiencies, gene therapy trials insert a normal copy of the faulty gene into the patient’s stem cells. Only very limited data exist for CVID-like disorders, and this is not routine care. The mechanism aims to permanently correct the immune defect. At present, such treatments remain research-level and are only available in specialized centers.

3. Optimized immunoglobulin replacement as functional immune “regeneration”
   Although Ig products are not stem cell therapies, regular, lifelong IVIG or SCIG acts as a continuous “passive immune system,” restoring the antibody arm of immunity. Over years, this dramatically reduces severe infections and can partly reverse or stabilize organ damage, especially when started early. In this sense, optimized Ig therapy is the core “regenerative” treatment for infection risk in CVID.

4. Biologic agents to control damaging immune over-activity
   Targeted biologic drugs such as rituximab (anti-CD20) or other monoclonal antibodies can control severe autoimmunity or granulomatous disease in CVID, indirectly “protecting” organs from immune-mediated destruction. They do not boost immunity; instead, they rebalance it by suppressing harmful immune responses. Such treatments are reserved for complex cases and given in specialist centers.

5. Growth-factor support in specific cell-line defects
   If a CVID patient has associated neutropenia or other bone-marrow problems, drugs such as granulocyte colony-stimulating factor (G-CSF) may be used to raise neutrophil counts temporarily. These cytokines act on bone-marrow stem and progenitor cells to increase production of specific blood cells, reducing certain infection risks. They are not routine in standard CVID but may be used when indicated.

6. Future cell-based therapies (experimental)
   Researchers are exploring ways to use modified regulatory T cells or mesenchymal stem cells to calm down chronic inflammation and autoimmunity in immune disorders. For CVID, such therapies remain experimental and are not part of routine care. If used at all, they would be given only in controlled clinical trials with strict safety monitoring.

---

Surgeries or procedures and why they are done

1. Functional endoscopic sinus surgery (FESS)
   In patients with severe chronic sinusitis that does not respond to medicines, FESS opens blocked sinus drainage pathways. This allows mucus and pus to drain more freely and improves penetration of nasal sprays and irrigations. In CVID, the goal is to reduce the frequency of sinus infections and improve quality of life.

2. Bronchoscopy with lavage and biopsy
   Bronchoscopy involves passing a flexible camera into the lungs to collect fluid and tissue samples. In CVID, doctors use it to identify persistent infections, check for unusual organisms and assess granulomatous or interstitial lung disease. This helps guide antibiotic or immunosuppressive treatment and monitor disease progression.

3. Lung resection for localized, destroyed segments
   Rarely, a localized part of the lung can become severely damaged by repeated infection (for example, abscess or destroyed lobe). In such cases, surgical removal of the worst segment can reduce chronic infection burden and risk of severe bleeding, though it is only considered after all medical options have been tried.

4. Splenectomy (removal of spleen) in selected cases
   Some patients with CVID develop immune thrombocytopenia or hemolytic anemia that does not respond to drugs. Splenectomy may be considered to reduce immune destruction of blood cells. However, removal of the spleen increases infection risk, so lifelong vaccines and sometimes antibiotic prophylaxis are needed afterward, and the decision is made very carefully.

5. Lymph node or organ biopsy
   Because CVID raises lymphoma risk and can mimic other inflammatory diseases, doctors sometimes remove part or all of a lymph node, gut segment or other tissue for biopsy. This helps distinguish benign immune enlargement from cancer or granulomatous disease, which then guides treatment choice and intensity.

---

Key prevention strategies

1. Lifelong, well-managed immunoglobulin replacement to keep IgG levels protective and infections low.

2. Early diagnosis and treatment of each infection to prevent structural lung and sinus damage.

3. Up-to-date vaccinations for family members and avoidance of live vaccines in the patient.

4. Avoiding tobacco smoke and other airway irritants to protect lung tissue.

5. Regular follow-up with an immunologist and lung specialist to monitor organs and adjust therapies.

6. Healthy diet, weight management and exercise to strengthen general health and resilience.

7. Safe travel and infection-aware lifestyle choices, especially during outbreaks or in high-risk seasons.

8. Careful use of immunosuppressive drugs, always balancing benefits against infection risk.

9. Cancer screening according to age and risk, plus attention to warning signs such as unexplained weight loss or swollen nodes.

10. Psychological support and education to maintain adherence to treatment and encourage timely help-seeking.

---

When to see a doctor or go to emergency care

People with common variable agammaglobulinemia / CVID should contact their doctor promptly if they have any of the following:

• Fever, new cough, shortness of breath, chest pain, or coughing up colored sputum, which may signal pneumonia.

• Severe or repeated sinus, ear or throat infections that do not get better with usual treatment.

• Persistent diarrhea, blood in the stool, severe belly pain or weight loss suggesting gut involvement.

• Easy bruising, frequent nosebleeds, very heavy periods or signs of anemia such as extreme tiredness and pale skin.

• New, painless lumps in the neck, underarms or groin, night sweats or unexplained weight loss, which may need urgent evaluation for lymphoma.

Emergency care is needed for breathing difficulty, chest pain, confusion, very high fever, severe dehydration or any rapid worsening symptoms.

Regular planned visits (often every 3–6 months) with the immunologist and other specialists should continue even when the patient feels well, to monitor IgG levels, organs and treatment side effects.

---

What to eat and what to avoid

1. Eat: balanced meals with good protein (fish, eggs, lean meat, legumes) to support tissue repair and immune cell production.

2. Eat: plenty of fruits and vegetables of different colors, which provide vitamins, antioxidants and fiber that support gut and immune health.

3. Eat: whole grains such as brown rice, oats and whole-wheat bread to keep energy stable and support gut bacteria.

4. Eat: healthy fats (olive oil, nuts, seeds, oily fish) instead of trans-fats or large amounts of saturated fat.

5. Eat: enough fluids (water, oral rehydration solutions in diarrhea) to prevent dehydration during infections.

6. Avoid: raw or undercooked meat, eggs, unpasteurized milk and unsafe street food, especially when traveling, to reduce food-borne infections.

7. Avoid: excessive sugar-sweetened drinks and ultra-processed snacks, which add calories without necessary nutrients and may worsen weight or metabolic health.

8. Avoid: heavy alcohol use, because it directly harms immune function and the liver, especially when taking many medicines.

9. Avoid: fad “immune-boosting” supplements without medical advice; some may interact with drugs or be contaminated.

10. Adjust: special diets (for example, gluten-free or lactose-reduced) only when clearly needed and supervised by a clinician or dietitian, especially in those with CVID-related enteropathy.

---

Frequently asked questions (FAQs)

1. Is common variable agammaglobulinemia / CVID curable?
   At present, CVID is not usually curable, but it is very treatable. Lifelong immunoglobulin replacement greatly reduces serious infections and improves life expectancy, especially when started early. Experimental options like stem cell or gene therapy are not standard for typical CVID and are reserved for very special situations or trials.

2. Will I need immunoglobulin infusions for life?
   Most people with true CVID need lifelong IVIG or SCIG, because their own B cells cannot reliably produce adequate antibodies. If Ig therapy is stopped, infections usually return and organ damage can progress. Doctors sometimes adjust dose or route but rarely stop treatment permanently.

3. Which is better: IVIG or SCIG?
   Both IVIG and SCIG replace antibodies effectively. IVIG is given every 3–4 weeks in hospital or infusion centers and can cause ups and downs in IgG levels. SCIG is given at home more often (weekly to monthly, depending on product) and keeps IgG steadier, with fewer systemic side effects but more local site reactions. The “best” route is the one that maintains control of infections and fits the patient’s lifestyle.

4. Can CVID be diagnosed in adults, or is it only a childhood disease?
   CVID can appear at any age, from childhood to late adulthood. Many people are diagnosed in their 20s–40s after years of recurrent infections. Because symptoms are often non-specific, diagnosis is sometimes delayed until someone notices a pattern and tests immunoglobulin levels and vaccine responses.

5. Is CVID inherited? Will my children get it?
   CVID has a complicated genetic background. In some families, clear single-gene defects are found; in others, multiple genetic and environmental factors play a role. Family members may have related immune problems or be completely healthy. Genetic counseling can help discuss risks for children and whether family members should be screened.

6. Can I have a normal life expectancy with CVID?
   With early diagnosis and consistent Ig therapy plus good infection prevention, many patients now live close to normal life spans. Risk is higher in those diagnosed late, with severe lung disease, liver disease, autoimmunity or cancer, so regular specialist care and healthy lifestyle choices are very important.

7. Can I work, study and travel?
   Many people with CVID can have active jobs, attend school and travel, especially once treatment is stable. They may need some adjustments, such as flexible scheduling for infusions, more sick leave during infection seasons and extra planning for travel (carrying medical letters and medicines).

8. Are there special precautions for surgery or dental work?
   Before surgery or invasive dental procedures, the surgical and anesthesia teams should know about the CVID diagnosis and current Ig therapy. Infections must be treated or prevented with appropriate antibiotics, and recent Ig infusion history should be reviewed. Good dental hygiene lowers the need for invasive work in the first place.

9. Can I get routine vaccines like the flu shot?
   Inactivated vaccines such as the yearly influenza shot and some COVID-19 vaccines are generally recommended, although the antibody response may be reduced. Live vaccines are usually avoided in the patient but encouraged for household contacts. Your immunologist will give a personalized vaccination plan.

10. Why do I still get some infections even on Ig therapy?
    Immunoglobulin greatly reduces serious infections but cannot make the immune system completely normal. Lung damage, resistant bacteria, viral infections and structural sinus or ear problems may still cause episodes of illness. Adjusting Ig dose, adding prophylactic antibiotics or treating structural problems can help further.

11. Can I breastfeed if I have CVID?
    Many women with CVID can breastfeed safely if they are otherwise stable and not taking certain medications that pass into breast milk. Breast milk itself contains antibodies that may help protect the baby. Decisions about breastfeeding should be made with both the immunologist and obstetrician, considering maternal health and drug safety.

12. Is pregnancy safe with CVID?
    Pregnancy is possible in CVID, but it needs careful planning. Ig doses may need adjustment as blood volume increases, and infections must be managed quickly. Some drugs (like certain immunosuppressants) are not safe in pregnancy and may need to be changed beforehand. Multidisciplinary care with immunology and high-risk obstetrics is recommended.

13. Do I need cancer screening earlier than other people?
    Because CVID raises risk of lymphoma and some gastrointestinal cancers, clinicians may recommend closer monitoring with physical exams, blood tests, imaging and age-appropriate cancer screening (such as colonoscopy). Any new, persistent lumps, night sweats or unexpected weight loss should be checked quickly.

14. Are “immune-boosting” herbs or megadose vitamins useful?
    There is little high-quality evidence that herbal or megadose vitamin products can correct the antibody defect in CVID. Some may interact with prescription medicines or cause harm. It is safer to focus on proven treatments such as Ig replacement, good nutrition, exercise and vaccination of contacts, and to discuss any supplement with the doctor first.

15. What is the single most important thing I can do?
    The single most important action is to stay closely linked with an experienced immunology team and adhere to your immunoglobulin replacement schedule. Combined with healthy lifestyle habits and early treatment of infections, this gives the best chance of a long, active life with common variable agammaglobulinemia / CVID.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: February 26, 2025.